Recurrent Pregnancy Loss Clinical Trial
Official title:
Meditation and Mindfulness for Recurrent Pregnancy Loss
In the Danish Recurrent Pregnancy Loss Unit in Rigshospitalet in Copenhagen recurrent
pregnancy loss (RPL) is defined as three og more consecutive pregnancy losses in accordance
with current European guidelines.
RPL affects approximately 3% of couples trying to achieve parenthood. Most cases of RPL are
unexplained and have no effective treatment to improve the chance of a live birth.
42% of the women referred to RPL Unit in Rigshospitalet has a high stress level where as it's
22% in the background population trying to achieve parenthood. It's also known that 8,8 % of
RPL patients have a depression at referral where as it's 2,2 % in the background population
trying to achieve parenthood.
The study is a RCT including 62 patients - 31 in each arm. One arm will be taught in
meditation and mindfulness three courses over a 7 week period. This group will also do
meditation every day for 7 weeks. The other arm will have no intervention.
This study will investigate if a 7 weeks course in meditation and mindfulness is a useful
tool to reduce stress and the psychological consequences for women and their partner treated
in RPL Unit in Rigshospitalet, Copenhagen. Furthermore this study will investigate if there's
a marital benefit such as reinforcement in their relationsship from practicing meditation and
mindfulness.
There is no previous study that has investigated meditation and mindfulness for RPL.
This study has the potential to establish mental health support as a supplement to the
medical and clinical treatment for RPL patients.
Status | Recruiting |
Enrollment | 64 |
Est. completion date | June 30, 2020 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 46 Years |
Eligibility |
Inclusion Criteria: - Women with RPL - Speaking, reading and understanding Danish - Have given a written consent - Have a male partner - Have a stress score > 16 points on Perceived Stress Scale Exclusion Criteria: - If the patient is pregnant on inclusion day - If the patient already is practing meditation and mindfulness - If the patient has a depression - If the patient develops a depression after inclusion in either arm |
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet | Copenhagen | Østerbro |
Lead Sponsor | Collaborator |
---|---|
Henriette Svarre Nielsen, MD, DMSc |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perceived Stress Scale (PSS) | Change from baseline to 7 weeks after date of first course day measured by Perceived Stress Scale. PSS is a validated 10-item-self-reporting scale for stress symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress). The higher score the more stress. | 7 weeks | |
Primary | Perceived Stress Scale (PSS) | Change from baseline to 12 months after date of first course day measured by the Perceived Stress Scale. PSS is a validated 10-item-self-reporting scale for stress symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress). The higher score the more stress. | 12 months | |
Secondary | COMPI Fertility Problem Stress Scale | Change from baseline to 7 weeks after date of first course day using the COMPI Fertility Problem Stress Scale. The COMPI Fertility Problem Stress Scale is a validated scale measuring the impact of RPL on the woman and her interpersonal relationships. Two questions asking if the experience of RPL has been stressful for the woman with five answering options. Followed by seven sub questions asking how big a load RPL has been for the patients interpersonal life with four answering options. The lower the score the higher stress. |
7 weeks | |
Secondary | Marital Benefit Scale | Change in marital benefit from baseline to 7 weeks after date of first course day using the COMPI Marital Benefit Scale. The COMPI Marital Benefit Scale has two questions asking what the RPL have mattered for their relationship/mariage: Five options to answer: totally disagree, partly disagree, neither agree or disagree, partly agree, totally agree. Answering "Totally agree" on both questions is defined as a high marital benefit. |
7 weeks | |
Secondary | COMPI Fertility Problem Stress Scale | Change in fertility problem stress from baseline to 12 months after date of first course day using the COMPI Fertility Problem Stress Scale. The COMPI Fertility Problem Stress Scale is a validated scale measuring the impact of RPL on the woman and her interpersonal relationships. Two questions used to assess how big a impact RPL has for the patient with five answering options. Followed by seven sub questions asking how big a load RPL has been for the patients interpersonal life with four answering options. The lower the score the higher stress. |
12 months | |
Secondary | Marital Benefit | Change in marital benefit from baseline to 12 months after date of first course day using the COMPI Marital Benefit Scale. The COMPI Marital Benefit Scale has two questions asking what the RPL have mattered for their relationship/mariage: Five options to answer: totally disagree, partly disagree, neither agree or disagree, partly agree, totally agree. Answering "Totally agree" on both questions is defined as a high marital benefit. |
12 months | |
Secondary | Major Depression Index (MDI) | Change in depression score from baseline to 12 months after date of first course day. Major Depression Index is a validated self-rating depression scale, which is used both clinically and in epidemiological studie. The 6-point Likert scale ranges from 0 (no depression) to 50 (extreme depression). | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04718233 -
Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss
|
Phase 2 | |
Recruiting |
NCT01946945 -
Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis
|
Phase 2 | |
Completed |
NCT02572154 -
Sperm DNA Fragmentation in Recurrent Pregnancy Loss
|
N/A | |
Completed |
NCT03174951 -
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
|
Phase 2 | |
Recruiting |
NCT05444283 -
Genomic Predictors of Recurrent Pregnancy Loss
|
||
Active, not recruiting |
NCT04621773 -
Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
|
||
Recruiting |
NCT02990403 -
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
|
Phase 4 | |
Recruiting |
NCT02990390 -
The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla
|
N/A | |
Not yet recruiting |
NCT05612620 -
Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05520112 -
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
|
Phase 1/Phase 2 | |
Suspended |
NCT04397042 -
SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05341856 -
Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL
|
Early Phase 1 | |
Recruiting |
NCT06007560 -
Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss
|
N/A | |
Completed |
NCT02386384 -
TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure
|
N/A | |
Recruiting |
NCT01635426 -
Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
|
Phase 2/Phase 3 | |
Suspended |
NCT01546350 -
Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH
|
Phase 2 | |
Completed |
NCT00721591 -
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
|
N/A | |
Terminated |
NCT00564174 -
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
|
N/A | |
Completed |
NCT04455256 -
Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05237843 -
Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
|
Phase 1 |